$ACON Balance Sheet | Understand Stock

$ACON

$1.92 -$0.01 (0.52%) Close

$ACON Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022
ASSETS
Current assets:
Cash
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Deferred Compensation
Prepaid expense
Other current assets

Total current assets
Non-current assets:
Total
Total non-current assets
Intangible assets, net

Total non-current assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities
Accounts payable
Accrued and other liabilities
Promissory note payable
Preferred dividends payable
Note payable, net of discount
Warrant liability
Liability to issue equity

Total current liabilities
Total liabilities
Preferred stock value
Series B3 Preferred Stock
SeriesBPreferredStockMember
Series B1 Preferred Stock
Series B2 Preferred Stock
Series B 2 Preferred Stock
Series B 3 Preferred Stock
Series A Preferred Stock
Series B, Preferred Stock
Series B3 Preferred Stock
Series B1 Preferred Stock
Series B2 Preferred Stock
Series B Preferred Stock
Series B 1 Preferred Stock
Series C Preferred Stock

Additional paid-in capital - series B2 and B3 preferred Stock
Total mezzanine equity
Common stock - $.00001 par value, 200,000,000 authorized,2,462,250 and 854,371 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (See Note 11)
Common Stock
Total common stock - $.00001 par value, 200,000,000 authorized,2,462,250 and 854,371 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (See Note 11)
Additional paid-in capital
Accumulated deficit
Stockholders’ equity
Series B3 Preferred Stock
SeriesBPreferredStockMember
Series B1 Preferred Stock
Series B2 Preferred Stock
Series B3 Preferred Stock
Series B1 Preferred Stock
Series B2 Preferred Stock
Total stockholders’ equity

Total liabilities and stockholders’ equity

Comments